» Articles » PMID: 12509712

Diversity of Mutations and Distribution of Single Nucleotide Polymorphic Alleles in the Human Alpha-L-iduronidase (IDUA) Gene

Overview
Journal Genet Med
Publisher Elsevier
Specialty Genetics
Date 2003 Jan 2
PMID 12509712
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Mucopolysaccharidosis type I (MPS I) is an autosomal recessive disorder resulting from a deficiency of the lysosomal glycosidase, alpha-L-iduronidase (IDUA). Patients with MPS I present with variable clinical manifestations ranging from severe to mild. To facilitate studies of phenotype-genotype correlation, the authors performed molecular studies to detect mutations in MPS I patients and characterize single nucleotide polymorphism (SNP) in the gene.

Methods: Twenty-two unrelated MPS I patients were subjects for mutation detection using reverse transcriptional polymerase chain reaction (RT-PCR) and genomic PCR sequencing. Polymorphism analyses were performed on controls by restriction enzyme assays of PCR amplicons flanking nine intragenic single nucleotide polymorphic alleles.

Results: Eleven different mutations including two common mutations (Q70X, W402X), five recurrent mutations (D315Y, P533R, R621X, R628X, S633L), and four novel mutations (R162I, G208D, 1352delG, 1952del25bp) were identified from MPS I patients. Multiple SNP alleles coexisting with the disease-causing mutations were detected. Allelic frequencies for nine SNP alleles including A8, A20, Q33H, L118, N181, A314, A361T, T388, and T410 were determined.

Conclusions: The results provide further evidence for the mutational heterogeneity among MPS I patients and point out possible common haplotype structures in the gene.

Citing Articles

Long-Term Health Outcomes of Individuals With Pseudodeficiency Alleles in IDUA May Inform Newborn Screening Practices for Mucopolysaccharidosis Type I.

Grady L, Zoltick E, Zouk H, He W, Perez E, Clarke L Am J Med Genet A. 2024; 197(4):e63940.

PMID: 39559959 PMC: 11885009. DOI: 10.1002/ajmg.a.63940.


Mucopolysaccharidosis type I: founder effect of the p.P533R mutation in North Africa.

Chkioua L, El Fissi H, Amri Y, Sahli C, Bouzid F, Boudabous H BMC Genomics. 2024; 25(1):948.

PMID: 39385097 PMC: 11462811. DOI: 10.1186/s12864-024-10724-1.


Enzymatic testing for mucopolysaccharidosis type I in Kuwaiti newborns: a preliminary study toward newborn screening.

Alsharhan H, Haider M, Qadoura B, Ayed M, Dhaunsi G, Alkandari H Front Pediatr. 2024; 12:1376053.

PMID: 39077064 PMC: 11284113. DOI: 10.3389/fped.2024.1376053.


Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I.

Can N, Tran D, Bui T, Nguyen K, Nguyen H, Van Nguyen T Life (Basel). 2021; 11(11).

PMID: 34833038 PMC: 8621179. DOI: 10.3390/life11111162.


Mucopolysaccharidoses type I gene therapy.

Hurt S, Dickson P, Curiel D J Inherit Metab Dis. 2021; 44(5):1088-1098.

PMID: 34189746 PMC: 8525653. DOI: 10.1002/jimd.12414.